Tuspetinib is a convenient once daily oral agent, and the TUS+VEN+AZA triplet has the potential to treat the larger AML population in a mutation agnostic manner, not just narrow subpopulations.

It’s no secret that DeFi (decentralized finance) and AML (anti-money laundering) policies are difficult to align. Regulators and industry players advocate for the importance of regulation, but we face ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins Some states have laws and ethical rules regarding solicitation and ...

Trust and Company Service Providers (TCSPs) and other professionals, like accountants and lawyers registered for AML with a UK supervisor can register to become Authorised Corporate Service Providers ...

Layna Lou Durocher is an 18-month-old girl who was born with a rare gene mutation which makes her care very complex. Sydney Gardiner, Lanya’s mother, shares her story and the toll the condition ...

De Nederlandsche Bank (DNB) has imposed two administrative fines totaling 20 million euros on de Volksbank N.V. for serious regulatory violations, including failures in business operations and ...